Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 15 studies | 37% ± 17% | |
astrocyte | 12 studies | 30% ± 11% | |
type II pneumocyte | 9 studies | 34% ± 12% | |
fibroblast | 7 studies | 21% ± 4% | |
pericyte | 6 studies | 24% ± 4% | |
cardiac muscle cell | 5 studies | 18% ± 3% | |
glutamatergic neuron | 4 studies | 40% ± 6% | |
GABAergic neuron | 3 studies | 25% ± 4% | |
endothelial cell | 3 studies | 24% ± 6% | |
enteroendocrine cell | 3 studies | 31% ± 5% | |
interneuron | 3 studies | 61% ± 30% | |
neuron | 3 studies | 53% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 6604.46 | 2626 / 2642 | 99% | 119.14 | 701 / 705 |
thymus | 99% | 1024.40 | 644 / 653 | 87% | 17.63 | 529 / 605 |
adrenal gland | 100% | 2481.69 | 258 / 258 | 77% | 13.08 | 177 / 230 |
lung | 100% | 3600.51 | 576 / 578 | 70% | 10.58 | 805 / 1155 |
skin | 65% | 689.75 | 1170 / 1809 | 90% | 31.08 | 425 / 472 |
breast | 78% | 528.55 | 356 / 459 | 51% | 4.25 | 569 / 1118 |
prostate | 89% | 684.14 | 219 / 245 | 28% | 21.83 | 143 / 502 |
esophagus | 71% | 724.23 | 1028 / 1445 | 44% | 4.93 | 81 / 183 |
intestine | 73% | 669.62 | 703 / 966 | 31% | 2.89 | 165 / 527 |
pancreas | 13% | 55.09 | 42 / 328 | 85% | 10.50 | 151 / 178 |
spleen | 98% | 970.85 | 235 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 1995.57 | 828 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 782.29 | 1226 / 1335 | 0% | 0 | 0 / 0 |
liver | 54% | 258.13 | 121 / 226 | 25% | 2.27 | 100 / 406 |
bladder | 57% | 424.43 | 12 / 21 | 20% | 2.13 | 102 / 504 |
kidney | 45% | 355.67 | 40 / 89 | 32% | 3.41 | 284 / 901 |
uterus | 48% | 223.88 | 82 / 170 | 26% | 3.69 | 120 / 459 |
adipose | 69% | 432.54 | 834 / 1204 | 0% | 0 | 0 / 0 |
stomach | 45% | 347.43 | 162 / 359 | 24% | 2.07 | 69 / 286 |
ovary | 12% | 58.18 | 22 / 180 | 34% | 2.84 | 145 / 430 |
eye | 0% | 0 | 0 / 0 | 41% | 4.26 | 33 / 80 |
tonsil | 0% | 0 | 0 / 0 | 29% | 2.51 | 13 / 45 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.37 | 2 / 29 |
muscle | 1% | 4.49 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0048935 | Biological process | peripheral nervous system neuron development |
GO_0030154 | Biological process | cell differentiation |
GO_0007638 | Biological process | mechanosensory behavior |
GO_0007517 | Biological process | muscle organ development |
GO_0007411 | Biological process | axon guidance |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | ETV1 |
Protein name | ETS translocation variant 1 (Ets-related protein 81) ETS variant transcription factor 1 |
Synonyms | ER81 |
Description | FUNCTION: Transcriptional activator that binds to DNA sequences containing the consensus pentanucleotide 5'-CGGA[AT]-3' . Required for olfactory dopaminergic neuron differentiation; may directly activate expression of tyrosine hydroxylase (TH) (By similarity). . |
Accessions | ENST00000403685.5 [P50549-2] F8WEH6 ENST00000443137.5 ENST00000405358.8 B5MCT2 P50549 C9J9L1 ENST00000405192.6 [P50549-3] C9JX69 ENST00000421381.5 ENST00000443608.6 [P50549-4] C9JQH6 ENST00000438956.6 C9J0B7 ENST00000431887.5 ENST00000242066.10 [P50549-2] ENST00000403527.6 [P50549-6] ENST00000433547.1 C9J4P4 ENST00000430479.6 [P50549-1] ENST00000405218.6 [P50549-1] ENST00000438956.6 [P50549-5] ENST00000443608.6 |